Cargando…
Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
The World Health Organization (WHO) recommends that the cost-effectiveness (CE) of introducing new vaccines be considered before such a programme is implemented. However, in low- and middle-income countries (LMICs), it is often challenging to perform and interpret the results of model-based economic...
Autores principales: | Hutubessy, Raymond, Henao, Ana Maria, Namgyal, Pem, Moorthy, Vasee, Hombach, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117725/ https://www.ncbi.nlm.nih.gov/pubmed/21569407 http://dx.doi.org/10.1186/1741-7015-9-55 |
Ejemplares similares
-
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2011) -
Current anti-doping policy: a critical appraisal
por: Kayser, Bengt, et al.
Publicado: (2007) -
Critical appraisal of AMSTAR: challenges, limitations, and potential solutions from the perspective of an assessor
por: Faggion, Clovis Mariano
Publicado: (2015) -
Anomalous aortic origin of coronary arteries from the opposite sinus: A critical appraisal of risk
por: Peñalver, Josiah M, et al.
Publicado: (2012) -
Decision tools in health care: focus on the problem, not the solution
por: Liu, Joseph, et al.
Publicado: (2006)